The statistical analysis of the obtained test results revealed that the preoperative plasma concentrations of VEGF and the comparative marker CA 15-3 in patients with BC were significantly higher than the concentrations in the control group of healthy women. This evidence concerns the gene VEGFA and breast cancer.